Depletion of luminal pyridine nucleotides in the endoplasmic reticulum activates autophagy with the involvement of mTOR pathway

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Kapuy, Orsolya ^a   Bánhegyi, Gábor ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCOSE TRANSPORTER; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; METYRAPONE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; S6 KINASE; ANTIPORTER; MTOR PROTEIN, HUMAN; NUCLEOTIDE; PYRIDINE DERIVATIVE; SLC37A4 PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ADDITION REACTION; ARTICLE; AUTOPHAGY; CELL VIABILITY; CELLULAR PARAMETERS; CONTROLLED STUDY; DEPLETION; ENDOPLASMIC RETICULUM; GENE SILENCING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN DEPHOSPHORYLATION; DOWN REGULATION; HEPG2 CELL LINE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIPORTERS; AUTOPHAGY; CELL LINE, TUMOR; DOWN-REGULATION; ENDOPLASMIC RETICULUM; HEP G2 CELLS; HUMANS; MONOSACCHARIDE TRANSPORT PROTEINS; NADP; NUCLEOTIDES; PYRIDINES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84890068740     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/942431     Document Type: Article

References (27)

1. Csala M., Bánhegyi G., Benedetti A., Endoplasmic reticulum: a metabolic compartment. FEBS Letters 2006 580 9 2160 2165 2-s2.0-33645980003 10.1016/j.febslet.2006.03.050
2. Görlach A., Klappa P., Kietzmann T., The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxidants and Redox Signaling 2006 8 9-10 1391 1418 2-s2.0-33750902737 10.1089/ars.2006.8.1391 (Pubitemid 44726319)
3. Malhi H., Kaufman R. J., Endoplasmic reticulum stress in liver disease. Journal of Hepatology 2011 54 4 795 809 2-s2.0-79952708723 10.1016/j.jhep.2010. 11.005
4. Marcolongo P., Senesi S., Gava B., Fulceri R., Sorrentino V., Margittai É., Lizák B., Csala M., Bánhegyi G., Benedetti A., Metyrapone prevents cortisone-induced preadipocyte differentiation by depleting luminal NADPH of the endoplasmic reticulum. Biochemical Pharmacology 2008 76 3 382 390 2-s2.0-46649087941 10.1016/j.bcp.2008.05.027
5. Száraz P., Bánhegyi G., Benedetti A., Altered redox state of luminal pyridine nucleotides facilitates the sensitivity towards oxidative injury and leads to endoplasmic reticulum stress dependent autophagy in HepG2 cells. International Journal of Biochemistry and Cell Biology 2010 42 1 157 166 2-s2.0-70549099976 10.1016/j.biocel.2009.10.004
6. Marcolongo P., Piccirella S., Senesi S., Wunderlich L., Gerin I., Mandl J., Fulceri R., Bánhegyi G., Benedetti A., The glucose-6-phosphate transporter-hexose-6-phosphate dehydrogenase-11 β -hydroxysteroid dehydrogenase type 1 system of the adipose tissue. Endocrinology 2007 148 5 2487 2495 2-s2.0-34249814328 10.1210/en.2006-1472 (Pubitemid 46997033)
7. Walker E. A., Ahmed A., Lavery G. G., Tomlinson J. W., So Y. K., Cooper M. S., Ride J. P., Hughes B. A., Shackleton C. H. L., McKiernan P., Elias E., Chou J. Y., Stewart P. M., 11 β -Hydroxysteroid dehydrogenase type 1 regulation by intracellular glucose 6-phosphate provides evidence for a novel link between glucose metabolism and hypothalamo-pituitary-adrenal axis function. The Journal of Biological Chemistry 2007 282 37 27030 27036 2-s2.0-34848854245 10.1074/jbc.M704144200 (Pubitemid 47501934)
8. Bánhegyi G., Csala M., Benedetti A., Hexose-6-phosphate dehydrogenase: linking endocrinology and metabolism in the endoplasmic reticulum. Journal of Molecular Endocrinology 2009 42 4 283 289 2-s2.0-67449161934 10.1677/JME-08-0156
9. Kereszturi É., Kálmán F. S., Kardon T., Csala M., Bánhegyi G., Decreased prereceptorial glucocorticoid activating capacity in starvation due to an oxidative shift of pyridine nucleotides in the endoplasmic reticulum. FEBS Letters 2010 584 22 4703 4708 2-s2.0-78249242429 10.1016/j.febslet.2010.10.053
10. Bánhegyi G., Benedetti A., Fulceri R., Senesi S., Cooperativity between 11 β -hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum. The Journal of Biological Chemistry 2004 279 26 27017 27021 2-s2.0-3042595899 10.1074/jbc.M404159200 (Pubitemid 38812537)
11. Maser E., Netter K. J., Purification and properties of a metyrapone-reducing enzyme from mouse liver microsomes-this ketone is reduced by an aldehyde reductase. Biochemical Pharmacology 1989 38 18 3049 3054 2-s2.0-0024422513 10.1016/0006-2952(89)90014-2 (Pubitemid 19222951)
12. Ogata M., Hino S.-I., Saito A., Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 2006 26 24 9220 9231 10.1128/MCB.01453-06 (Pubitemid 44904418)
13. Walter P., Ron D., The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011 334 6059 1081 1086 2-s2.0-82255173966 10.1126/science.1209038
14. Levine B., Kroemer G., Autophagy in the pathogenesis of disease. Cell 2008 132 1 27 42 2-s2.0-37649005234 10.1016/j.cell.2007.12.018
15. Ravikumar B., Sarkar S., Davies J. E., Regulation of mammalian autophagy in physiology and pathophysiology. Physiological Reviews 2010 90 4 1383 1435 10.1152/physrev.00030.2009
16. Noda T., Ohsumi Y., Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. The Journal of Biological Chemistry 1998 273 7 3963 3966 2-s2.0-0032512636 10.1074/jbc.273.7.3963 (Pubitemid 28103257)
17. Watanabe R., Wei L., Huang J., mTOR signaling, function, novel inhibitors, and therapeutic targets. Journal of Nuclear Medicine 2011 52 4 497 500 2-s2.0-79954592882 10.2967/jnumed.111.089623
18. Hay N., Sonenberg N., Upstream and downstream of mTOR. Genes and Development 2004 18 16 1926 1945 2-s2.0-4043171462 10.1101/gad.1212704 (Pubitemid 39071573)
19. Zoncu R., Efeyan A., Sabatini D. M., mTOR: from growth signal integration to cancer, diabetes and ageing. Nature Reviews Molecular Cell Biology 2011 12 1 21 35 2-s2.0-78650510609 10.1038/nrm3025
20. Watanabe R., Tambe Y., Inoue H., Isono T., Haneda M., Isobe K.-I., Kobayashi T., Hino O., Okabe H., Chano T., GADD34 inhibits mammalian target of rapamycin signaling via tuberous sclerosis complex and controls cell survival under bioenergetic stress. International Journal of Molecular Medicine 2007 19 3 475 483 2-s2.0-33947538578
21. Uddin M. N., Ito S., Nishio N., Suganya T., Isobe K.-I., Gadd34 induces autophagy through the suppression of the mTOR pathway during starvation. Biochemical and Biophysical Research Communications 2011 407 4 692 698 2-s2.0-79955005054 10.1016/j.bbrc.2011.03.077
22. Wang S. Y., Kaufman R. J., The impact of the unfolded protein response on human disease. Journal of Cell Biology 2012 197 7 857 867 10.1083/jcb.201110131
23. Belkaid A., Copland I. B., Massillon D., Annabi B., Silencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: potential new anticancer target for curcumin. FEBS Letters 2006 580 15 3746 3752 2-s2.0-33745167272 10.1016/j.febslet.2006.05.071 (Pubitemid 43902814)
24. Bánhegyi G., Csala M., Benedetti A., Hexose-6-phosphate dehydrogenase: linking endocrinology and metabolism in the endoplasmic reticulum. Journal of Molecular Endocrinology 2009 42 4 283 289 2-s2.0-67449161934 10.1677/JME-08-0156
25. Kapuy O., Vinod P. K., Mandl J., Bnhegyi G., A cellular stress-directed bistable switch controls the crosstalk between autophagy and apoptosis. Molecular Biosystems 2013 9 2 296 306 10.1039/c2mb25261a
26. Choo A. Y., Blenis J., Not all substrates are treated equally Implications for mTOR, rapamycin-resistance and cancer therapy. Cell Cycle 2009 8 4 567 572 2-s2.0-61449235398
27. Nawroth R., Stellwagen F., Schulz W. A., Stoehr R., Hartmann A., Krause B. J., Gschwend J. E., Retz M., S6k1 and 4E-BP1 are independent regulated and control cellular growth in bladder cancer. PLoS ONE 2011 6 11 2-s2.0-81055144867 10.1371/journal.pone.0027509 e27509